SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-038087
Filing Date
2023-08-04
Accepted
2023-08-04 16:30:27
Documents
12
Period of Report
2023-08-01
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K brhc20056999_8k.htm   iXBRL 8-K 31321
  Complete submission text file 0001140361-23-038087.txt   167688

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20230801.xsd EX-101.SCH 3874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20230801_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20230801_pre.xml EX-101.PRE 16050
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc20056999_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 231144456
SIC: 2834 Pharmaceutical Preparations